Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
基本信息
- 批准号:7753521
- 负责人:
- 金额:$ 5.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdvanced Glycosylation End ProductsAminesAnimal ModelBiologicalBiological MarkersCellsChemicalsChemopreventionChemopreventive AgentChronicCollagenDataDermisDoseElastinEpidermisEventExperimental ModelsExtracellular Matrix ProteinsExtracellular ProteinHumanIn VitroInterventionKeratinLeadLightMeasuresMediatingMediator of activation proteinModelingMolecularMolecular TargetNatureNew AgentsPathway interactionsPhotosensitizationPhotosensitizing AgentsPreventive InterventionProductionProteinsRadiationReactive Oxygen SpeciesResearchRoleSimulateSinglet OxygenSkinSkin CarcinogenesisSkin TissueSolar EnergySourceStressStructural ProteinTestingTherapeuticThickTissue ModelUltraviolet Raysabsorptionbasechromophorecrosslinkextracellularin vivoin vivo Modelinnovationirradiationnovelpharmacophorephotoprotectionprototypereconstructionresponsesmall moleculetooltumor
项目摘要
This application aims to establish a causative role of skin structural proteins (keratin, collagen, and elastin) as
I endogenous UV-sensitizers in skin photodamage and evaluates modulation of these novel targets for
I chemoprevention of photocarcinogenesis and photoaging. Photooxidative stress initiated by solar irradiation
Iof endogenous sensitizers is a key mechanism of skin photodamage, but the molecular nature of the
photodynamic non-DNA chromophores responsible for light-driven production of reactive oxygen species
(ROS) is unknown. Pilot data summarized in the application support the hypothesis that UV chromophores
contained exclusively in extracellular matrix proteins of skin are potent endogenous photosensitizers. To test
Ithis hypothesis reconstructed epidermis, dermis, and full thickness human skin tissue equivalents will be
Iused to allow quantitative control of protein UV-chromophores of both enzymatic and non-enzymatic origin
"(aim 1). Sensitizer-dependent and independent ROS production in response to total and fractionated solar
UV light will be determined and results will be validated by direct chemical analyses (aim 2). Established
molecular and cellular biomarkers of photooxidative stress will be assessed as a function of sensitizer
content and radiation dose. Photosensitized enhancement of known biomarkers of photocarcinogenesis and
photoaging will be studied (aim 3). The therapeutic potential of physical quenchers of photoexcited states as
a novel class of topical chemopreventive agents for suppression of sensitized photodamage in reconstructed
human skin will be evaluated. Reconstructed human skin with controlled sensitizer content will be irradiated
and the chemopreventive potential of prototype quenchers as direct molecular antagonists of photoexcited
states will be evaluated. A novel secondary amine pharmacophore, which protects human skin cells against
photosensitization by physical deactivation of excited state molecules and singlet oxygen without chemical
Idepletion, will be tested as a prototype chemopreventive agent and derivatized for optimal topical delivery
I(aim 4). The efficacy of the lead quencher of photoexcited states will be tested in an animal model of
Iphotocarcinogenesis. This study will validate endogenous structural skin components as novel molecular
Itargets for chemoprevention in skin photocarcinogenesis and photoaging and lead to a new class of
Iphotoprotective agents.
本应用程序旨在建立皮肤结构蛋白(角蛋白,胶原蛋白和弹性蛋白)的致病作用
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage.
让阳光照射进来:皮肤光损伤治疗的机制和潜力。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Wondrak,GeorgT
- 通讯作者:Wondrak,GeorgT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELAINE L JACOBSON其他文献
ELAINE L JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELAINE L JACOBSON', 18)}}的其他基金
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
7545687 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
6869984 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
6989089 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
7332241 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
7537180 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
7162509 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Endogenous photosensitizers in skin carcinogenesis
内源性光敏剂在皮肤癌发生中的作用
- 批准号:
7494192 - 财政年份:2005
- 资助金额:
$ 5.26万 - 项目类别:
Carbonyl scavengers for skin protection from glycation
用于保护皮肤免受糖化作用的羰基清除剂
- 批准号:
6691130 - 财政年份:2003
- 资助金额:
$ 5.26万 - 项目类别:
相似海外基金
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3776700 - 财政年份:
- 资助金额:
$ 5.26万 - 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3840306 - 财政年份:
- 资助金额:
$ 5.26万 - 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3855332 - 财政年份:
- 资助金额:
$ 5.26万 - 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
- 批准号:
5202002 - 财政年份:
- 资助金额:
$ 5.26万 - 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
- 批准号:
3754540 - 财政年份:
- 资助金额:
$ 5.26万 - 项目类别: